← Open Payments lookup

ALIMATU NABIE: Open Payments

NPI 1053820621 · MONTGOMERY VILLAGE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,397 in 180 payments from 11 companies in 2025. Trend: 2023 $1,896 · 2024 $1,680 · 2025 $4,397

Food & beverage: $4,277Education: $120
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.25$761
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)22$732
Otsuka America Pharmaceutical, Inc.22$555
ABBVIE INC.24$420
Alkermes, Inc.21$368
Lundbeck LLC13$360
E.R. Squibb & Sons, L.L.C.12$276
Neurocrine BioSciences, Inc.14$262
Supernus Pharmaceuticals, Inc.6$252
Takeda Pharmaceuticals U.S.A., Inc.18$234

Products named: CAPLYTA, REXULTI, UZEDY, VRAYLAR, ARISTADA, COBENFY, INGREZZA, Qelbree.

Industry payments across MD — which companies pay providers there.